Press Digest: Wall Street Journal - November 3

Aurinia Pharmaceuticals

03/11/2025 05:38

Nov 3 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

- Temasek-owned Mapletree Investments and CapitaLand Investment CAPN.SI are considering a business combination, with plans potentially starting next year.

- FDA official George Tidmarsh, who resigned Sunday, was accused in a lawsuit by Canada's Aurinia Pharmaceuticals AUPH.O of seeking a bribe and defaming a drug.

- U.S. President Trump threatened U.S. military action in Nigeria and to halt aid, citing the targeting of Christians by Islamist terrorists.

- China's manufacturing PMI, a private gauge, decreased to 50.6 in October from 51.2 in September, indicating slower expansion.

- The policy-setting board of the Reserve Bank of Australia is expected to leave the official cash rate unchanged on Tuesday.

- OPEC+ will boost oil production by 137,000 barrels a day in December, matching increases from October and November.

 (Compiled by Bengaluru newsroom)

 ((globalnewsmonitoring@thomsonreuters.com))